Plerixafor and resatorvid inhibit hepatitis B virus in vitro by upregulating elongation factor Tu GTP-binding domain containing 2

MLA

Jinyuan Cai, et al. “Plerixafor and Resatorvid Inhibit Hepatitis B Virus in Vitro by Upregulating Elongation Factor Tu GTP-Binding Domain Containing 2.” Frontiers in Cellular and Infection Microbiology, vol. 13, Feb. 2023. EBSCOhost, https://doi.org/10.3389/fcimb.2023.1118801.

APA

Jinyuan Cai, Yuwen Li, Pingping Hu, Ruirui Xu, Hui Yuan, Wen Zhang, Tiantong Feng, Rui Liu, Wenting Li, & Chuanlong Zhu. (2023). Plerixafor and resatorvid inhibit hepatitis B virus in vitro by upregulating elongation factor Tu GTP-binding domain containing 2. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1118801

Chicago

Jinyuan Cai, Yuwen Li, Pingping Hu, Ruirui Xu, Hui Yuan, Wen Zhang, Tiantong Feng, Rui Liu, Wenting Li, and Chuanlong Zhu. 2023. “Plerixafor and Resatorvid Inhibit Hepatitis B Virus in Vitro by Upregulating Elongation Factor Tu GTP-Binding Domain Containing 2.” Frontiers in Cellular and Infection Microbiology 13 (February). doi:10.3389/fcimb.2023.1118801.